PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$12.01
+0.81 (+7.23%)
Open$11.54
Previous Close$11.20
Day High$12.16
Day Low$11.35
52W High$18.31
52W Low$2.21
Volume—
Avg Volume1.80M
Market Cap975.42M
P/E Ratio—
EPS$-3.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+322.5% upside
Current
$12.01
$12.01
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 195.03M | 173.93M | 162.51M |
| Net Income | -246,428,401 | 52.15M | 46.06M |
| Profit Margin | -126.4% | 30.0% | 28.4% |
| EBITDA | -177,702,637 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |